Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer

BACKGROUND: Abrogation of growth factor-dependent signaling represents an effective therapeutic strategy for patients with colorectal cancer (CRC). Here we evaluated the effectiveness of targeting the epidermal growth factor (EGF) receptors HER-2 and HER-3 in the three cell lines LS513, LS1034 and S...

Descripción completa

Detalles Bibliográficos
Autores principales: Conradi, Lena-Christin, Spitzner, Melanie, Metzger, Anna-Lena, Kisly, Merle, Middel, Peter, Bohnenberger, Hanibal, Gaedcke, Jochen, Ghadimi, Michael B., Liersch, Torsten, Rüschoff, Joseph, Beißbarth, Tim, König, Alexander, Grade, Marian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727342/
https://www.ncbi.nlm.nih.gov/pubmed/31488078
http://dx.doi.org/10.1186/s12885-019-6051-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6727342/
https://www.ncbi.nlm.nih.gov/pubmed/31488078
http://dx.doi.org/10.1186/s12885-019-6051-0

Ejemplares similares